Stay updated on CAD106 and CNP520 in At-Risk Alzheimer's Clinical Trial
Sign up to get notified when there's something new on the CAD106 and CNP520 in At-Risk Alzheimer's Clinical Trial page.

Latest updates to the CAD106 and CNP520 in At-Risk Alzheimer's Clinical Trial page
- CheckyesterdayNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe web page has removed the section titled 'Helpful Links Provided by Novartis (Novartis Pharmaceuticals) Generation Program', which may have contained important resources or information related to the program.SummaryDifference0.2%
- Check23 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference0.7%
- Check30 days agoNo Change Detected
- Check37 days agoChange DetectedThe page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with a contact email for assistance.SummaryDifference0.7%
- Check44 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.0%
- Check59 days agoChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.0%
- Check66 days agoChange DetectedThe website has updated the 'type of intervention' feature from version 2.13.3 to 2.14.0, indicating a significant change in this functionality.SummaryDifference0.1%
Stay in the know with updates to CAD106 and CNP520 in At-Risk Alzheimer's Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CAD106 and CNP520 in At-Risk Alzheimer's Clinical Trial page.